K08 NS051843/NS/NINDS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2008	1
2010	2
2011	5
2013	1
2014	1
2024	0

1

REDD1/DDIT4-independent mTORC1 inhibition and apoptosis by glucocorticoids in thymocytes.

Wolff NC, McKay RM, Brugarolas J. Wolff NC, et al. Mol Cancer Res. 2014 Jun;12(6):867-77. doi: 10.1158/1541-7786.MCR-13-0625. Epub 2014 Mar 10. Mol Cancer Res. 2014. PMID: 24615339 Free PMC article.

2

Platelet-derived growth factor/vascular endothelial growth factor receptor inactivation by sunitinib results in Tsc1/Tsc2-dependent inhibition of TORC1.

Tran TA, Kinch L, Peña-Llopis S, Kockel L, Grishin N, Jiang H, Brugarolas J. Tran TA, et al. Mol Cell Biol. 2013 Oct;33(19):3762-79. doi: 10.1128/MCB.01570-12. Epub 2013 Jul 22. Mol Cell Biol. 2013. PMID: 23878397 Free PMC article.

3

Regulation of TFEB and V-ATPases by mTORC1.

Peña-Llopis S, Vega-Rubin-de-Celis S, Schwartz JC, Wolff NC, Tran TA, Zou L, Xie XJ, Corey DR, Brugarolas J. Peña-Llopis S, et al. EMBO J. 2011 Jul 29;30(16):3242-58. doi: 10.1038/emboj.2011.257. EMBO J. 2011. PMID: 21804531 Free PMC article.

4

Sirolimus and temsirolimus for epithelioid angiomyolipoma.

Wolff N, Kabbani W, Bradley T, Raj G, Watumull L, Brugarolas J. Wolff N, et al. J Clin Oncol. 2010 Feb 10;28(5):e65-8. doi: 10.1200/JCO.2009.26.3061. Epub 2010 Jan 4. J Clin Oncol. 2010. PMID: 20048172 No abstract available.

5

Interplay between pVHL and mTORC1 pathways in clear-cell renal cell carcinoma.

Kucejova B, Peña-Llopis S, Yamasaki T, Sivanand S, Tran TA, Alexander S, Wolff NC, Lotan Y, Xie XJ, Kabbani W, Kapur P, Brugarolas J. Kucejova B, et al. Mol Cancer Res. 2011 Sep;9(9):1255-65. doi: 10.1158/1541-7786.MCR-11-0302. Epub 2011 Jul 28. Mol Cancer Res. 2011. PMID: 21798997 Free PMC article.

6

Uncoupling hypoxia signaling from oxygen sensing in the liver results in hypoketotic hypoglycemic death.

Kucejova B, Sunny NE, Nguyen AD, Hallac R, Fu X, Peña-Llopis S, Mason RP, Deberardinis RJ, Xie XJ, Debose-Boyd R, Kodibagkar VD, Burgess SC, Brugarolas J. Kucejova B, et al. Oncogene. 2011 May 5;30(18):2147-60. doi: 10.1038/onc.2010.587. Epub 2011 Jan 10. Oncogene. 2011. PMID: 21217781 Free PMC article.

7

Cell-type-dependent regulation of mTORC1 by REDD1 and the tumor suppressors TSC1/TSC2 and LKB1 in response to hypoxia.

Wolff NC, Vega-Rubin-de-Celis S, Xie XJ, Castrillon DH, Kabbani W, Brugarolas J. Wolff NC, et al. Mol Cell Biol. 2011 May;31(9):1870-84. doi: 10.1128/MCB.01393-10. Epub 2011 Mar 7. Mol Cell Biol. 2011. PMID: 21383064 Free PMC article.

8

Structural analysis and functional implications of the negative mTORC1 regulator REDD1.

Vega-Rubin-de-Celis S, Abdallah Z, Kinch L, Grishin NV, Brugarolas J, Zhang X. Vega-Rubin-de-Celis S, et al. Biochemistry. 2010 Mar 23;49(11):2491-501. doi: 10.1021/bi902135e. Biochemistry. 2010. PMID: 20166753 Free PMC article.

9

Sirolimus in metatastic renal cell carcinoma.

Brugarolas J, Lotan Y, Watumull L, Kabbani W. Brugarolas J, et al. J Clin Oncol. 2008 Jul 10;26(20):3457-60. doi: 10.1200/JCO.2008.16.4590. J Clin Oncol. 2008. PMID: 18612163 No abstract available.

10

Exploring a glycolytic inhibitor for the treatment of an FH-deficient type-2 papillary RCC.

Yamasaki T, Tran TA, Oz OK, Raj GV, Schwarz RE, Deberardinis RJ, Zhang X, Brugarolas J. Yamasaki T, et al. Nat Rev Urol. 2011 Mar;8(3):165-71. doi: 10.1038/nrurol.2010.234. Epub 2011 Feb 8. Nat Rev Urol. 2011. PMID: 21304509 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year